Dyno

formerly Dyno Therapeutics

Powering genetic agency

Watertown, United States · Founded 2018 · $118.0M raised

Employees
51–200
Founded
2018
Business Model
B2B
Website
dynotx.com
Total Funding
$118.0M
Last Round
$100.0M Series AMay 2021
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 8 investors for this company. The full record is or through the API.

About

Dyno Therapeutics is a Watertown, Massachusetts-based AI and biotech company building high-performance genetic technologies to unlock the potential of next-generation medicine. The company applies machine learning to design optimized adeno-associated virus (AAV) capsids and vectors, improving the delivery, efficiency, and safety of gene therapies. Dyno partners with pharmaceutical and biotech companies through its Frontiers Network to advance AAV vectors for neurological, muscular, and other genetic disease indications, with a stated mission to enable genetic agency for all patients.

Summary

Dyno is an Artificial Intelligence company based in Watertown, United States, founded in 2018. It has raised $118.0M in total across 3 rounds, most recently a $100.0M Series A round in May 2021. Investors include Polaris Partners, CRV (Charles River) and Andreessen Horowitz.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMay 2021
$100.0M

Sign up to see all 3 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Dyno on Indexed.vc
<a href="https://indexed.vc/companies/dyno"><img src="https://indexed.vc/api/badge/company/dyno" alt="Dyno on Indexed.vc" width="260" height="76" /></a>